HealthQuill vaccine
The USFDA has approved Pfizer Inc.’s vaccine to treat deadly meningococcal disease in young adults between 10 years and 25 years.
Drugs Health Pharma

Pfizer’s vaccine for meningococcal disease gets FDA approval

HQ Team October 21, 2023: The USFDA has approved Pfizer Inc.’s vaccine to treat deadly meningococcal disease in young adults between 10 years.

Read More
Sheela, 19, a student studying medicine in India’s southern city of Thiruvananthapuram, was bitten by a stray pup at a hostel in the hospital.
Drugs Health Pharma

Opinion: Sheela’s death shook me, stray dogs with rabies scare me

By Dr K. Leelamoni October 16, 2023: Sheela, 19, a student studying medicine in India’s southern city of Thiruvananthapuram, was bitten by a.

Read More
The WHO’s rapid test will be used as the first method to diagnose tuberculosis and the global health agency will license one TB vaccine in a bid to reach 90% of the patients and to end the epidemic.
Drugs Health Pharma

WHO sets up body to develop, licence a new vaccine to fight tuberculosis

HQ Team September 23, 2023: The WHO’s rapid test will be used as the first method to diagnose tuberculosis and the global health.

Read More
The UNICEF and the private-public partnership Gavi Vaccine Alliance will roll out its malaria vaccine for the first time in nine African countries to fight one of the deadliest diseases in the continent, according to the WHO.
Drugs Health Pharma

A dozen African nations to receive 18 million shots of malaria vaccine

HQ Team July 6, 2023: The UNICEF and the private-public partnership Gavi Vaccine Alliance will roll out its malaria vaccine for the first.

Read More
Australian researchers shed light on animal-human virus transmission
Drugs Health Pharma

Australian researchers shed light on animal-human virus transmission

HQ Team June 23, 2023: Australian researchers have unearthed the process of how an infectious virus enters human cells from animals. The researchers.

Read More
lyme disease
Climate Health Medical Pharma

Vaccine for Lyme disease soon

Pfizer and Moderna are ready to introduce a vaccine for Lyme disease by 2030.

Read More
The FDA cleared the emergency use of bivalent Pfizer-Biotech COVID-19 vaccine for a single dose booster in children aged six months to four years.
Drugs Medical Pharma

FDA nod for Pfizer-Biotech vaccine booster for children

The FDA cleared the emergency use of bivalent Pfizer-Biotech COVID-19 vaccine for a single dose booster in children aged six months to four.

Read More
Novavax, a US biotechnology company, announced it would deliver 1.5 million doses of its COVID-19 adjuvanted vaccine to the government.
Drugs Health Medical Pharma

Novavax to supply 1.5m COVID-19 vaccine doses to US

Novavax, a US biotechnology company, announced it would deliver 1.5 million doses of its COVID-19 adjuvanted vaccine to the government.

Read More
Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.
Drugs Health Pharma

Stelis Biopharma to be pure play CDMO firm, may list ‘near term’

Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.

Read More
Bharat Biotech, an Indian maker of vaccines for infectious diseases, has rolled out the world's first nasal Covid-19 drops as a booster dose, according to a company statement.
Drugs Medical Pharma

India’s Bharat Biotech rolls out Covid-19 nasal drop vaccine

Bharat Biotech, an Indian maker of vaccines for infectious diseases, has rolled out the world's first nasal Covid-19 drops as a booster dose,.

Read More